Is LFWD or OM more profitable?

Outset Medical has a net margin of -63.06% compared to Lifeward's net margin of -141.28%. Outset Medical's return on equity of -61.67% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -141.28% -235.86% -81.72% Outset Medical -63.06% -61.67% -28.25%

Is LFWD or NRXS more profitable?

Lifeward has a net margin of -141.28% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -141.28% -235.86% -81.72% NeurAxis -492.76% N/A -641.25%

Which has preferable earnings & valuation, CVRX or LFWD?

Lifeward has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.58 -$53.31M -$1.98 N/A Lifeward $22.03M 0.95 -$19.91M -$16.82 N/A

Is CVRX or LFWD more profitable?

CVRx has a net margin of -84.93% compared to Lifeward's net margin of -141.28%. CVRx's return on equity of -152.35% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Lifeward -141.28% -235.86% -81.72%

Which has stronger earnings & valuation, NNOX or LFWD?

Lifeward has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nano-X Imaging $13.02M 5.21 -$75.02M -$1.58 N/A Lifeward $22.03M 0.95 -$19.91M -$16.82 N/A

Is NNOX or LFWD more profitable?

Lifeward has a net margin of -141.28% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Nano-X Imaging -716.44% -70.96% -62.26% Lifeward -141.28% -235.86% -81.72%

Which has higher earnings and valuation, NYXH or LFWD?

Lifeward has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nyxoah $11.33M 5.61 -$101.92M -$2.52 N/A Lifeward $22.03M 0.95 -$19.91M -$16.82 N/A

Is NYXH or LFWD more profitable?

Lifeward has a net margin of -141.28% compared to Nyxoah's net margin of -443.16%. Nyxoah's return on equity of -178.90% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -443.16% -178.90% -81.83% Lifeward -141.28% -235.86% -81.72%

Lifeward (LFWD) Competitors

$7.39 +0.10 (+1.37%)

Closing price 04:00 PM Eastern

Extended Trading

$7.40 +0.00 (+0.07%)

As of 04:10 PM Eastern

Compare

LFWD vs. OM, NRXS, CVRX, NNOX, and NYXH

Should you buy Lifeward stock or one of its competitors? Lifeward's main competitors and comparable companies include Outset Medical (OM), NeurAxis (NRXS), CVRx (CVRX), Nano-X Imaging (NNOX), and Nyxoah (NYXH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Lifeward compare to Outset Medical?

Lifeward (NASDAQ:LFWD) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

Lifeward has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.96, meaning that its share price is 96% more volatile than the broader market.

Outset Medical has a net margin of -63.06% compared to Lifeward's net margin of -141.28%. Outset Medical's return on equity of -61.67% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
Outset Medical	-63.06%	-61.67%	-28.25%

26.8% of Lifeward shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Comparatively, 2.5% of Outset Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Outset Medical had 1 more articles in the media than Lifeward. MarketBeat recorded 2 mentions for Outset Medical and 1 mentions for Lifeward. Outset Medical's average media sentiment score of 0.62 beat Lifeward's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Neutral
Outset Medical	Positive

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 35.32%. Outset Medical has a consensus price target of $10.00, indicating a potential upside of 132.56%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts plainly believe Outset Medical is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Lifeward has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.95	-$19.91M	-$16.82	N/A
Outset Medical	$119.48M	0.68	-$81.65M	-$4.09	N/A

Summary

Outset Medical beats Lifeward on 12 of the 16 factors compared between the two stocks.

How does Lifeward compare to NeurAxis?

Lifeward (NASDAQ:LFWD) and NeurAxis (NASDAQ:NRXS) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

In the previous week, Lifeward and Lifeward both had 1 articles in the media. NeurAxis' average media sentiment score of 0.91 beat Lifeward's score of 0.00 indicating that NeurAxis is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Neutral
NeurAxis	Positive

NeurAxis has lower revenue, but higher earnings than Lifeward. NeurAxis is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.95	-$19.91M	-$16.82	N/A
NeurAxis	$5.32M	14.27	-$14.63M	-$0.78	N/A

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 21.1% of NeurAxis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Lifeward has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market. Comparatively, NeurAxis has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 35.32%. NeurAxis has a consensus price target of $13.00, indicating a potential upside of 115.23%. Given NeurAxis' stronger consensus rating and higher probable upside, analysts plainly believe NeurAxis is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Lifeward has a net margin of -141.28% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
NeurAxis	-492.76%	N/A	-641.25%

Summary

NeurAxis beats Lifeward on 9 of the 15 factors compared between the two stocks.

How does Lifeward compare to CVRx?

CVRx (NASDAQ:CVRX) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

75.3% of CVRx shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 1.5% of Lifeward shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

CVRx presently has a consensus target price of $5.30, indicating a potential upside of 57.27%. Lifeward has a consensus target price of $10.00, indicating a potential upside of 35.32%. Given CVRx's higher possible upside, analysts plainly believe CVRx is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

CVRx has a net margin of -84.93% compared to Lifeward's net margin of -141.28%. CVRx's return on equity of -152.35% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Lifeward	-141.28%	-235.86%	-81.72%

In the previous week, CVRx had 6 more articles in the media than Lifeward. MarketBeat recorded 7 mentions for CVRx and 1 mentions for Lifeward. CVRx's average media sentiment score of 0.02 beat Lifeward's score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Overall Sentiment
CVRx	Neutral
Lifeward	Neutral

Lifeward has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.58	-$53.31M	-$1.98	N/A
Lifeward	$22.03M	0.95	-$19.91M	-$16.82	N/A

CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Summary

CVRx beats Lifeward on 12 of the 15 factors compared between the two stocks.

How does Lifeward compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

In the previous week, Nano-X Imaging had 2 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Nano-X Imaging and 1 mentions for Lifeward. Lifeward's average media sentiment score of 0.00 beat Nano-X Imaging's score of -0.40 indicating that Lifeward is being referred to more favorably in the news media.

Company	Overall Sentiment
Nano-X Imaging	Neutral
Lifeward	Neutral

Nano-X Imaging has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

Lifeward has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	5.21	-$75.02M	-$1.58	N/A
Lifeward	$22.03M	0.95	-$19.91M	-$16.82	N/A

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Nano-X Imaging presently has a consensus price target of $4.33, suggesting a potential upside of 402.12%. Lifeward has a consensus price target of $10.00, suggesting a potential upside of 35.32%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, equities analysts plainly believe Nano-X Imaging is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Lifeward has a net margin of -141.28% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-716.44%	-70.96%	-62.26%
Lifeward	-141.28%	-235.86%	-81.72%

Summary

Nano-X Imaging beats Lifeward on 9 of the 16 factors compared between the two stocks.

How does Lifeward compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings.

Nyxoah has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

26.8% of Lifeward shares are owned by institutional investors. 1.5% of Lifeward shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Lifeward has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	5.61	-$101.92M	-$2.52	N/A
Lifeward	$22.03M	0.95	-$19.91M	-$16.82	N/A

Nyxoah presently has a consensus target price of $4.26, suggesting a potential upside of 159.88%. Lifeward has a consensus target price of $10.00, suggesting a potential upside of 35.32%. Given Nyxoah's higher probable upside, equities research analysts plainly believe Nyxoah is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Lifeward has a net margin of -141.28% compared to Nyxoah's net margin of -443.16%. Nyxoah's return on equity of -178.90% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-443.16%	-178.90%	-81.83%
Lifeward	-141.28%	-235.86%	-81.72%

In the previous week, Nyxoah had 2 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Nyxoah and 1 mentions for Lifeward. Lifeward's average media sentiment score of 0.00 beat Nyxoah's score of -0.35 indicating that Lifeward is being referred to more favorably in the news media.

Company	Overall Sentiment
Nyxoah	Neutral
Lifeward	Neutral

Summary

Lifeward beats Nyxoah on 8 of the 14 factors compared between the two stocks.

Get Lifeward News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFWD vs. The Competition

Export

Metric	Lifeward	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$20.65M	$5.96B	$7.34B	$12.72B
Dividend Yield	N/A	1.74%	2.53%	11.02%
P/E Ratio	-0.44	26.05	270.94	24.14
Price / Sales	0.95	70.20	634.79	96.73
Price / Cash	N/A	33.27	78.57	53.12
Price / Book	1.71	6.27	13.14	6.25
Net Income	-$19.91M	$149.30M	$3.46B	$347.86M
7 Day Performance	-0.40%	0.98%	3.23%	1.57%
1 Month Performance	4.82%	9.22%	8.82%	5.24%
1 Year Performance	-3.58%	7.82%	27.70%	17.87%

Lifeward Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFWD Lifeward	1.8892 of 5 stars	$7.39 +1.4%	$10.00 +35.3%	-1.2%	$20.65M	$22.03M	N/A	60
OM Outset Medical	3.0274 of 5 stars	$4.29 +2.6%	$10.00 +133.1%	-70.5%	$80.65M	$119.48M	N/A	520
NRXS NeurAxis	1.931 of 5 stars	$6.33 +1.0%	$13.00 +105.5%	+145.7%	$79.43M	$5.32M	N/A	19
CVRX CVRx	3.7659 of 5 stars	$2.80 +2.0%	$5.30 +89.0%	-59.6%	$74.70M	$56.65M	N/A	160	News Coverage
NNOX Nano-X Imaging	4.1143 of 5 stars	$0.92 +4.1%	$4.33 +369.5%	-78.7%	$64.67M	$13.02M	N/A	190	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFWD) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifeward (LFWD) Competitors

LFWD vs. OM, NRXS, CVRX, NNOX, and NYXH

How does Lifeward compare to Outset Medical?

Summary

How does Lifeward compare to NeurAxis?

Summary

How does Lifeward compare to CVRx?

Summary

How does Lifeward compare to Nano-X Imaging?

Summary

How does Lifeward compare to Nyxoah?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFWD vs. The Competition

Lifeward Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifeward (LFWD) Competitors

LFWD vs. OM, NRXS, CVRX, NNOX, and NYXH

How does Lifeward compare to Outset Medical?

Which has more risk and volatility, LFWD or OM?

Is LFWD or OM more profitable?

Do institutionals and insiders believe in LFWD or OM?

Does the media favor LFWD or OM?

Do analysts prefer LFWD or OM?

Which has higher valuation & earnings, LFWD or OM?

Summary

How does Lifeward compare to NeurAxis?

Does the media favor LFWD or NRXS?

Which has higher valuation and earnings, LFWD or NRXS?

Do insiders & institutionals have more ownership in LFWD or NRXS?

Which has more volatility and risk, LFWD or NRXS?

Do analysts recommend LFWD or NRXS?

Is LFWD or NRXS more profitable?

Summary

How does Lifeward compare to CVRx?

Do institutionals & insiders believe in CVRX or LFWD?

Do analysts recommend CVRX or LFWD?

Is CVRX or LFWD more profitable?

Does the media prefer CVRX or LFWD?

Which has preferable earnings & valuation, CVRX or LFWD?

Which has more risk and volatility, CVRX or LFWD?

Summary

How does Lifeward compare to Nano-X Imaging?

Does the media refer more to NNOX or LFWD?

Which has more volatility & risk, NNOX or LFWD?

Which has stronger earnings & valuation, NNOX or LFWD?

Do insiders & institutionals have more ownership in NNOX or LFWD?

Do analysts prefer NNOX or LFWD?

Is NNOX or LFWD more profitable?

Summary

How does Lifeward compare to Nyxoah?

Which has more volatility and risk, NYXH or LFWD?

Do institutionals and insiders hold more shares of NYXH or LFWD?

Which has higher earnings and valuation, NYXH or LFWD?

Do analysts prefer NYXH or LFWD?

Is NYXH or LFWD more profitable?

Does the media favor NYXH or LFWD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFWD vs. The Competition

Lifeward Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools